Safety and Efficacy of Real-World Use of Everolimus for Kidney Transplant Patients: Post-Marketing Surveillance in Japan.

被引：0
|
作者：
Harada, H. [1 ]
Watarai, Y. [2 ]
Uchida, J. [3 ]
Kamisawa, O. [4 ]
机构：
[1] Sapporo City Gen Hosp, Sapporo, Hokkaido, Japan
[2] Nagoya Daini Red Cross Hosp, Nagoya, Japan
[3] Osaka City Univ, Osaka, Japan
[4] Novartis Pharma KK, Tokyo, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B134
引用
收藏
页码：675 / 675
页数：1
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY OF EVEROLIMUS IN MAINTENANCE KIDNEY TRANSPLANT PATIENTS: A 2-YEAR POST-MARKETING SURVEILLANCE STUDY IN JAPAN
    Watanabe, Yoko
    Hayase, Naomi
    Yamada, Mariko
    Kaneko, Shuhei
    [J]. TRANSPLANTATION, 2020, 104 (09) : S629 - S629
  • [2] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
    Hayase, Naomi
    Yamada, Mariko
    Kaneko, Shuhei
    Watanabe, Yoko
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (06) : 660 - 673
  • [3] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
    Naomi Hayase
    Mariko Yamada
    Shuhei Kaneko
    Yoko Watanabe
    [J]. Clinical and Experimental Nephrology, 2021, 25 : 660 - 673
  • [4] The real-world use of istradefylline for Parkinsons disease: Post-marketing surveillance of safety and effectiveness in Japan
    Takahashi, Makio
    Itou, Satoru
    Horiguchi, Shuji
    Tsuji, Yukie
    [J]. NEUROLOGY, 2022, 98 (18)
  • [5] Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance study
    Fujimoto, Nobukazu
    Akamatsu, Ayumi
    Honda, Chikara
    Aoki, Miki
    Ohe, Yuichiro
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024,
  • [6] Safety and effectiveness of avelumab in patients with curatively unresectable merkel cell carcinoma (MCC) in a real-world setting: A post-marketing surveillance in Japan.
    Uhara, Hisashi
    Kiyohara, Yoshio
    Sato, Masashi
    Endo, Shehla
    Song, Bingbing
    Sato, Yoshinori
    Tanaka, Yutaro
    Kambe, Anzu
    Yamazaki, Naoya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database
    Wataya, Takafumi
    Takasaki, Sakura
    Hoshino, Misuzu
    Makioka, Haruki
    Nakamura, Genshu
    Matsuda, Naoto
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (08) : 851 - 863
  • [8] Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance
    Hirotsugu Uemura
    Yoshihiko Tomita
    Norio Nonomura
    Kenji Yoshizaki
    Takafumi Nakao
    Nobuo Shinohara
    [J]. International Journal of Clinical Oncology, 2022, 27 : 1061 - 1067
  • [9] Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance
    Uemura, Hirotsugu
    Tomita, Yoshihiko
    Nonomura, Norio
    Yoshizaki, Kenji
    Nakao, Takafumi
    Shinohara, Nobuo
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (06) : 1061 - 1067
  • [10] Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan
    Takayama, Koichi
    Kojima, Ai
    Honda, Chikara
    Nakayama, Masahiro
    Kanemata, Satomi
    Endo, Toshimitsu
    Muro, Kei
    [J]. CANCER MEDICINE, 2024, 13 (09):
12345